A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes

Frederick L. Locke,R Agarwal,Rangesh Kunnavakkam,K. Van Besien,Richard A. Larson,Olatoyosi Odenike,Lucy A. Godley,Hongtao Liu,M. Le Beau,Sandeep Gurbuxani,Michael J. Thirman,Dorothy A. Sipkins,C White,Andrew S. Artz,Wendy Stock

A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes

2013

Frederick L. Locke
R Agarwal
Rangesh Kunnavakkam
K. Van Besien
Richard A. Larson
Olatoyosi Odenike
Lucy A. Godley
Hongtao Liu
M. Le Beau
Sandeep Gurbuxani
Michael J. Thirman
Dorothy A. Sipkins
C White
Andrew S. Artz
Wendy Stock

A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes

Keywords:

Clofarabine
Arabinonucleosides
Refractory
Hematopoietic stem cell transplantation
Transplantation Conditioning
Immunology
Myelodysplastic syndromes
Leukemia
Medicine
Allogeneic transplantation
adenine nucleotide

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations